The North America Antihyperlipidemic Drugs Market is experiencing sustained growth due to the increasing burden of cardiovascular diseases, widespread adoption of cholesterol-lowering therapies, and robust healthcare infrastructure. The region benefits from high healthcare spending, comprehensive insurance coverage, and strong emphasis on preventive cardiovascular care. Advancements in...